Rolling Out6h
A revolutionary shift in schizophrenia treatment
Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.
New research continues to link marijuana with schizophrenia. Experts say it's not so simple
“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...
Anavex: Further Validation Of Blarcamesine With Schizophrenia Data In 2025
Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...
Anavex projects EMA feedback on Alzheimer's drug by year-end 2025
Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...
Anavex Life Sciences Corp.: Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmac ...
Everyday Health4d
Cognitive Symptoms of Schizophrenia: Why They Happen and What Can Be Done About Them
If you or a loved one has been diagnosed with schizophrenia ... blog for nurses and enjoys mentoring new nurses, providing support as they begin their often-challenging career.